Twist Bioscience agrees with Lilly TuneLab for antibody discovery
Twist Bioscience announced an agreement with Lilly TuneLab, an AI/ML drug discovery platform created by Eli Lilly, to advance antibody drug discovery using Twist’s antibody characterization data services.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.